关注
Ali Bazarbachi, MD,PhD
Ali Bazarbachi, MD,PhD
Professor of Medicine, Hematology and Oncology American University of Beirut
在 aub.edu.lb 的电子邮件经过验证
标题
引用次数
引用次数
年份
The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
Experts in Chronic Myeloid Leukemia
Blood, The Journal of the American Society of Hematology 121 (22), 4439-4442, 2013
6562013
Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting
K Tsukasaki, O Hermine, A Bazarbachi, L Ratner, JC Ramos, ...
Journal of Clinical Oncology 27 (3), 453-459, 2009
5962009
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
D Farge, C Frere, JM Connors, C Ay, AA Khorana, A Munoz, B Brenner, ...
The Lancet Oncology 20 (10), e566-e581, 2019
4572019
Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration
ZF Bashshur, A Bazarbachi, A Schakal, ZA Haddad, CP El Haibi, ...
American journal of ophthalmology 142 (1), 1-9, 2006
4382006
Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 51 (7), 906-912, 2016
4352016
Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study
B Yamout, R Hourani, H Salti, W Barada, T El-Hajj, A Al-Kutoubi, ...
Journal of neuroimmunology 227 (1-2), 185-189, 2010
4162010
Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes
A Bazarbachi, Y Plumelle, J Carlos Ramos, P Tortevoye, Z Otrock, ...
Journal of Clinical Oncology 28 (27), 4177-4183, 2010
3972010
Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation …
M Mohty, F Malard, M Abecassis, E Aerts, AS Alaskar, M Aljurf, M Arat, ...
Bone marrow transplantation 50 (6), 781-789, 2015
3962015
Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa
O Hermine, D Bouscary, A Gessain, P Turlure, V Leblond, N Franck, ...
New England Journal of Medicine 332 (26), 1749-1751, 1995
3051995
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
MT Daniel, M Koken, O Romagne, S Barbey, A Bazarbachi, M Stadler, ...
Blood 82 (6), 1858-1867, 1993
3001993
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ...
Bone marrow transplantation 49 (7), 865-872, 2014
2322014
Arsenic Trioxide and Interferon- Synergize to Induce Cell Cycle Arrest and Apoptosis in Human T-Cell Lymphotropic Virus Type I–Transformed Cells
A Bazarbachi, ME El-Sabban, R Nasr, F Quignon, C Awaraji, J Kersual, ...
Blood, The Journal of the American Society of Hematology 93 (1), 278-283, 1999
2131999
Revised adult T-cell leukemia-lymphoma international consensus meeting report
LB Cook, S Fuji, O Hermine, A Bazarbachi, JC Ramos, L Ratner, ...
Journal of Clinical Oncology 37 (8), 677-687, 2019
2122019
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow …
AJ Kansagra, NV Frey, M Bar, TW Laetsch, PA Carpenter, BN Savani, ...
Bone marrow transplantation 54 (11), 1868-1880, 2019
206*2019
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
D Farge, C Frere, JM Connors, AA Khorana, A Kakkar, C Ay, A Muñoz, ...
The Lancet Oncology 23 (7), e334-e347, 2022
2052022
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL)
G Kchour, M Tarhini, MM Kooshyar, H El Hajj, E Wattel, M Mahmoudi, ...
Blood, The Journal of the American Society of Hematology 113 (26), 6528-6532, 2009
2032009
How I treat adult T-cell leukemia/lymphoma
A Bazarbachi, F Suarez, P Fields, O Hermine
Blood, The Journal of the American Society of Hematology 118 (7), 1736-1745, 2011
2002011
High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey
H Rafatpanah, MR Hedayati-Moghaddam, F Fathimoghadam, ...
Journal of Clinical Virology 52 (3), 172-176, 2011
1922011
FLT3 inhibitors in acute myeloid leukemia: ten frequently asked questions
AI Antar, ZK Otrock, E Jabbour, M Mohty, A Bazarbachi
Leukemia 34 (3), 682-696, 2020
1872020
Arsenic-interferon-α–triggered apoptosis in HTLV-I transformed cells is associated with Tax down-regulation and reversal of NF-κB activation
ME El-Sabban, R Nasr, G Dbaibo, O Hermine, N Abboushi, F Quignon, ...
Blood, The Journal of the American Society of Hematology 96 (8), 2849-2855, 2000
1802000
系统目前无法执行此操作,请稍后再试。
文章 1–20